Document Detail


Disruptive technology: new medical advances are troublesome for even the most successful health systems and innovator health companies.
MedLine Citation:
PMID:  15185624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An independent expert panel conducted a multi-year research/education/advocacy initiative on the impact of the new drug-eluting stent technology. They conclude that this technology represents a "tipping point" in a series of transformative drugs and medical devices, often used in combination, and recommend that healthcare decision makers develop careful, data-based strategies to avoid the disruptiveness of these medical advances.
Authors:
Lawrence Michaelis; Joanne Vaul; Kathleen Chumer; Maureen Faul; Lisa Sheehan; Jack DeCerce
Related Documents :
11780294 - Bronchoscopic management of benign stenosis.
10174484 - Reclaiming our moral tradition. catholic teaching calls us to accept the limits of medi...
21082484 - Biotech pilgrims and the transnational quest for stem cell cures.
1908934 - Evaluation of medical technologies: a generalized roc analysis.
15361014 - A medical association hospital centered network for inter-institutional treatment in a ...
3092564 - Severe undernutrition in jamaica. kwashiorkor and marasmus: the disease of the weanling.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of cardiovascular management : the official journal of the American College of Cardiovascular Administrators     Volume:  15     ISSN:  1053-5330     ISO Abbreviation:  J Cardiovasc Manag     Publication Date:    2004 Mar-Apr
Date Detail:
Created Date:  2004-06-09     Completed Date:  2004-07-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9111437     Medline TA:  J Cardiovasc Manag     Country:  United States    
Other Details:
Languages:  eng     Pagination:  9-12     Citation Subset:  H    
Affiliation:
Northwestern Memorial Hospital, Chicago, IL, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Decision Making, Organizational
Delivery of Health Care / organization & administration
Diffusion of Innovation
Drug Delivery Systems*
Equipment and Supplies / adverse effects*
Stents*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Campylobacter and Salmonella control in chickens and the role of fermented food
Next Document:  Translational barriers and their effect upon cardiovascular revenues and reimbursement.